Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

MEDITRANS : revenue, balance sheet and financial ratios

MEDITRANS is a French company founded 29 years ago, specialized in the sector Transports routiers de fret interurbains. Based in MITRY-MORY (77290), this company of category PME shows in 2017 a revenue of 420 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - MEDITRANS (SIREN 411403819)
Indicator 2022 2019 2017
Revenue N/C N/C 419 794 €
Net income 33 397 € 57 194 € 3 934 €
EBITDA N/C N/C 44 806 €
Net margin N/C N/C 0.9%

Revenue and income statement

In 2022, MEDITRANS generates positive net income of 33 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2022: 4 k€ -> 33 k€.

Net income (2022) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

33 397 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 32%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 54%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2022) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

32.085%

Financial autonomy (2022) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

53.789%

Asset age ratio (2022) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

20.5%

Solvency indicators evolution
MEDITRANS

Sector positioning

Debt ratio
32.09 2022
2017
2019
2022
Q1: 4.17
Med: 35.5
Q3: 96.31
Good -12 pts over 3 years

In 2022, the debt ratio of MEDITRANS (32.09) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
53.79% 2022
2017
2019
2022
Q1: 17.2%
Med: 33.57%
Q3: 50.37%
Excellent

In 2022, the financial autonomy of MEDITRANS (53.8%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Repayment capacity
1.46 years 2017
2017
Q1: 0.0 years
Med: 0.26 years
Q3: 1.81 years
Average

In 2017, the repayment capacity of MEDITRANS (1.46) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 286.00. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2022) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

286.005

Liquidity indicators evolution
MEDITRANS

Sector positioning

Liquidity ratio
286.0 2022
2017
2019
2022
Q1: 128.83
Med: 173.71
Q3: 245.18
Excellent

In 2022, the liquidity ratio of MEDITRANS (286.00) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Interest coverage
4.6x 2017
2017
Q1: 0.0x
Med: 0.63x
Q3: 3.67x
Excellent

In 2017, the interest coverage of MEDITRANS (4.6x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2022) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2022) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2022) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2022) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
MEDITRANS

Positioning of MEDITRANS in its sector

Comparison with sector Transports routiers de fret interurbains

Valuation estimate

Based on 56 transactions of similar company sales in 2022, the value of MEDITRANS is estimated at 101 166 € (range 45 214€ - 188 175€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2022
56 tx
45k€ 101k€ 188k€
101 166 € Range: 45 214€ - 188 175€
NAF 5 année 2022

Valuation method used

Net Income Multiple
33 397 € × 3.0x = 101 166 €
Range: 45 214€ - 188 175€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 56 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Transports routiers de fret interurbains)

Compare MEDITRANS with other companies in the same sector:

Voir toutes les statistiques du secteur Transports routiers de fret interurbains

Frequently asked questions about MEDITRANS

What is the revenue of MEDITRANS ?

The revenue of MEDITRANS in 2017 is 420 k€.

Is MEDITRANS profitable?

Yes, MEDITRANS generated a net profit of 33 k€ in 2022.

Where is the headquarters of MEDITRANS ?

The headquarters of MEDITRANS is located in MITRY-MORY (77290), in the department Seine-et-Marne.

Where to find the tax return of MEDITRANS ?

The tax return of MEDITRANS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does MEDITRANS operate?

MEDITRANS operates in the sector Transports routiers de fret interurbains (NAF code 49.41A). See the 'Sector positioning' section above to compare the company with its competitors.